Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.
AIDS Program, San Francisco General Hospital and University of California, 94110, USA.
F M
FM
Hecht
R M
RM
Grant
C J
CJ
Petropoulos
B
B
Dillon
M A
MA
Chesney
H
H
Tian
N S
NS
Hellmann
N I
NI
Bandrapalli
L
L
Digilio
B
B
Branson
J O
JO
Kahn
D019380:Anti-HIV Agents / Q000627:therapeutic use; D018562:Disease Transmission, Infectious; D018432:Drug Resistance, Multiple / Q000235:genetics*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy / Q000635:transmission* / Q000821:virology*; D015497:HIV-1 / Q000145:classification* / Q000187:drug effects / Q000235:genetics; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011480:Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood; D012194:RNA-Directed DNA Polymerase / Q000235:genetics; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D012725:Sexual Behavior
D019380:Anti-HIV Agents; D011480:Protease Inhibitors; D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors; D012194:RNA-Directed DNA Polymerase